Marshall Wace North America L.P. bought a new stake in shares of HCP, Inc. (NYSE:HCP) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 5,800 shares of the real estate investment trust’s stock, valued at approximately $182,000.
A number of other institutional investors have also made changes to their positions in HCP. Massey Quick Simon & CO. LLC acquired a new position in shares of HCP in the 1st quarter worth $25,000. Pacific Center for Financial Services grew its holdings in shares of HCP by 123.5% during the fourth quarter. Pacific Center for Financial Services now owns 894 shares of the real estate investment trust’s stock valued at $25,000 after buying an additional 494 shares in the last quarter. Executive Wealth Management LLC purchased a new position in HCP in the fourth quarter valued at about $30,000. Prime Capital Investment Advisors LLC purchased a new position in HCP in the fourth quarter valued at about $37,000. Finally, Bessemer Group Inc. grew its stake in HCP by 32.9% in the fourth quarter. Bessemer Group Inc. now owns 1,332 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 330 shares in the last quarter. 95.50% of the stock is currently owned by hedge funds and other institutional investors.
In other news, Director Christine Garvey sold 3,405 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $29.80, for a total value of $101,469.00. Following the completion of the transaction, the director now owns 5,348 shares in the company, valued at approximately $159,370.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.13% of the stock is currently owned by corporate insiders.
HCP (NYSE:HCP) last issued its quarterly earnings data on Wednesday, May 1st. The real estate investment trust reported $0.44 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.01. The business had revenue of $436.15 million for the quarter, compared to the consensus estimate of $442.20 million. HCP had a return on equity of 18.05% and a net margin of 59.96%. The firm’s revenue was down 9.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.48 EPS. On average, equities analysts predict that HCP, Inc. will post 1.74 earnings per share for the current fiscal year.
A number of research analysts have commented on HCP shares. Morgan Stanley set a $111.00 target price on Procter & Gamble and gave the company a “buy” rating in a research note on Thursday, March 28th. KeyCorp cut GTT Communications from an “overweight” rating to a “sector weight” rating in a research report on Monday, July 1st. Raymond James initiated coverage on Adverum Biotechnologies in a research report on Thursday, June 13th. They issued a “market perform” rating for the company. Finally, TheStreet raised Rent-A-Center from a “c” rating to a “b-” rating in a research report on Tuesday, May 7th. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $30.41.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
See Also: Range Trading
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.